Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,994 | 141,150 | 163,152 | 182,160 | 322,536 |
| Marketable Securities | 213,591 | 208,399 | 180,870 | 139,215 | N/A |
| Receivables | 188,318 | 190,904 | 199,444 | 196,231 | 152,380 |
| Inventories | 188,833 | 192,405 | 184,500 | 173,370 | 160,342 |
| Income taxes - deferred | 39,829 | 36,767 | 37,509 | 36,291 | 37,689 |
| Other current assets | 62,069 | 63,771 | 67,559 | 81,642 | 86,451 |
| TOTAL | $821,634 | $833,396 | $833,034 | $808,909 | $759,398 |
| Non-Current Assets | |||||
| PPE Net | 333,026 | 320,337 | 326,041 | 309,827 | 303,587 |
| Intangibles | 234,843 | 239,042 | 237,222 | 236,843 | 249,572 |
| Other Non-Current Assets | 85,490 | 84,435 | 81,073 | 75,435 | 71,654 |
| TOTAL | $653,359 | $643,814 | $644,336 | $622,105 | $624,813 |
| Total Assets | $1,474,993 | $1,477,210 | $1,477,370 | $1,431,014 | $1,384,211 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 52,648 | 53,614 | 58,212 | 44,183 | 44,743 |
| Accrued Expenses | 205,530 | 203,738 | 190,441 | 177,942 | 195,351 |
| TOTAL | $856,761 | $824,766 | $775,428 | $803,445 | $820,906 |
| Non-Current Liabilities | |||||
| Long Term Debt | 597,085 | 599,556 | 622,796 | 522,350 | 350,000 |
| Deferred Revenues | 25,583 | N/A | 28,775 | 31,820 | 31,812 |
| Other Non-Current Liabilities | 28,657 | 29,654 | 31,308 | 31,043 | 32,373 |
| TOTAL | $702,227 | $691,247 | $693,391 | $593,490 | $445,716 |
| Total Liabilities | $1,558,988 | $1,516,013 | $1,468,819 | $1,396,935 | $1,266,622 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,638 | 90,964 | 92,005 | 93,591 | 94,251 |
| Common Shares | 10,258 | 10,213 | 10,235 | 10,226 | 10,195 |
| Retained earnings | 318,356 | 274,005 | 231,070 | 1,721,893 | 1,675,299 |
| Other shareholders' equity | -37,143 | -31,829 | -16,432 | -18,622 | -3,198 |
| TOTAL | $-83,995 | $-38,803 | $8,551 | $34,079 | $117,589 |
| Total Liabilities And Equity | $1,474,993 | $1,477,210 | $1,477,370 | $1,431,014 | $1,384,211 |